TNF and inflammatory bowel disease: The current IBD therapeutic armamentarium is confirmed by 5-aminosalicylic acid (5-ASA) compounds, immunosuppressants such as methotrexate and thiopurine, anti-tumor necrosis factor (TNF) alpha, anti-integrin, and anti-IL-12 and 23 among the monoclonal antibodies.